Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD – Get Free Report) was the target of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 67,129 shares, a decrease of 66.3% from the September 15th total of 199,073 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average trading volume of 2,041,132 shares, the short-interest ratio is currently 0.0 days.
Hong Kong Pharma Digital Technology Price Performance
Shares of HKPD traded up $0.01 during mid-day trading on Wednesday, reaching $0.11. The company had a trading volume of 244,381 shares, compared to its average volume of 1,427,461. The firm has a fifty day simple moving average of $0.22 and a 200-day simple moving average of $0.41. Hong Kong Pharma Digital Technology has a fifty-two week low of $0.10 and a fifty-two week high of $1.72. The company has a quick ratio of 3.75, a current ratio of 3.86 and a debt-to-equity ratio of 0.01.
Hong Kong Pharma Digital Technology (NASDAQ:HKPD – Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported ($0.04) EPS for the quarter. The firm had revenue of $3.15 million during the quarter.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on HKPD
Hong Kong Pharma Digital Technology Company Profile
Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.
See Also
- Five stocks we like better than Hong Kong Pharma Digital Technology
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Hong Kong Pharma Digital Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hong Kong Pharma Digital Technology and related companies with MarketBeat.com's FREE daily email newsletter.
